The Cooper Companies, Inc.
Financials
Valuation Metrics
The Cooper Companies, Inc.'s Market Cap is $11.62B. At end of 2025 it was $16.12B. Ranked #822 of 3,116 in US market (top 26%), #254 of 1,472 on NASDAQ (top 17%), #57 of 203 in Health Care Equipment & Services (top 28%) by Market Cap.
Investment Metrics(as of 2026-10-30)
| Metric | Value | Rank |
|---|---|---|
| Size | ||
| Market Cap | $11.62B | US#822/3,116 Sec#57/203 |
| Revenue | $4.24B | US#975/3,116 Sec#57/203 |
| Net Income | $570M | US#773/3,116 Sec#44/203 |
| Total Assets | $12.67B | US#852/3,116 Sec#40/203 |
| Net Assets | $8.33B | US#488/3,116 Sec#26/203 |
| Employees | 15,000 | US#673/3,116 Sec#53/203 |
| Value | ||
| P/E | 20.37x | US#1,139/3,116 Sec#23/203 |
| P/B | 1.39x | US#819/3,116 Sec#34/203 |
| PEG | 0.51x | US#607/3,116 Sec#23/203 |
| P/S | 2.74x | US#1,603/3,116 Sec#109/203 |
| EV/EBITDA | 15.39x | US#1,563/3,116 Sec#60/203 |
| FCF Yield | 5.84% | US#1,229/3,116 Sec#50/203 |
| Profitability | ||
| ROE | 6.85% | US#1,689/3,116 Sec#81/203 |
| ROA | 4.50% | US#1,136/3,116 Sec#75/203 |
| Op. Margin | 12.85% | US#1,350/3,116 Sec#54/203 |
| Revenue Growth | 4.73% | US#1,791/3,116 Sec#135/203 |
| Earnings Growth | 39.85% | US#571/3,116 Sec#31/203 |
| Financial Health | ||
| Debt Ratio | 52.17% | US#594/3,116 Sec#67/203 |
| Total Debt | $2.54B | US#1,025/3,116 Sec#48/203 |
| FCF | $678M | US#757/3,116 Sec#44/203 |
| Cash | $155M | US#1,932/3,116 Sec#117/203 |
| Current Ratio | 1.22x | US#1,970/3,116 Sec#169/203 |
| Net Debt/EBITDA | 2.63x | US#1,513/3,116 Sec#94/203 |
| Dividend | ||
| Div. Growth | 0.00% | US—/3,116 Sec—/203 |
| Performance | ||
| 1Y Return | -15.09% | US#2,228/3,116 Sec#149/203 |
| 1M Return | 5.31% | US#1,077/3,116 Sec#108/203 |
| From 52W High | -33.73% | US#2,122/3,116 Sec#160/203 |
| 1Y MDD | -36.82% | US#1,752/3,116 Sec#107/203 |
| Trading | ||
| Volume | 7,324,067 shares | US#1,260/3,116 Sec#70/203 |
| Trading Value | $438M | US#996/3,116 Sec#71/203 |
| Per Share | ||
| EPS | $2.92 | US#1,073/3,116 Sec#57/203 |
| BPS | $42.68 | US#563/3,116 Sec#39/203 |
Company Info
The Cooper Companies, Inc., together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment offers spherical, toric, and multifocal contact lenses that address vision challenges, such as astigmatism, presbyopia, and myopia. Its CooperSurgical segment focuses on family and women's health care, which provides fertility products and services, medical devices, and contraception, as well as cryostorage, such as cord blood and cord tissue storage. This segment offers Paragard, a hormone-free intrauterine device; and fertility consumables and equipment, donor gamete services, and genomic services, including genetic testing. The company sells its products to distributors, group purchasing organizations, eye care and health care professionals, including independent practices, corporate retailers, hospitals and clinics, and authorized resellers. The Cooper Companies, Inc. was founded in 1958 and is headquartered in San Ramon, California.